Company / Total Debt
Tandem Diabetes Care Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$310.0M
FY2025
5-year range
$285.0M / $310.0M
FY2021-FY2025
Trend
+0.6%
vs FY2024
Sector context
#72 of 100
Health Care
What the data says
At $310M, Tandem Diabetes Care's total debt ranks #29 of 100 in the Health Care sector. Total Debt has increased for 4 consecutive years, from $81M in FY2016 to $310M in FY2025.
Based on SEC 10-K filings.
$310M in FY2025.
Increased from $285M to $310M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#29 of 100 in Health CareTop 28% of 100This company $310.0M Sector average $4.6B
▼
-93.2% below sector average
Key checks
Key Insights
- In FY2025, total debt increased 0.6% year-over-year.
- Ranks #72 out of 100 companies in the Health Care sector.
- Lowest total debt in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $310.0M | +0.6% |
| FY2024 | $308.3M | +8.2% |
| FY2023 | $285.0M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $82.7M | +2.0% |
| FY2016 | $81.1M | +168.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026